UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive (Loss)
Balance, beginning of period (in shares) at Dec. 31, 2021		81,712
Balance, beginning of period at Dec. 31, 2021	$ 416,088	$ 817	$ 145,810	$ 276,449	$ (6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(242)
Repurchase of common stock	(22,583)	$ (2)	(22,581)
Issuance of common stock for stock compensation plans (in shares)		297
Issuance of common stock for stock compensation plans	(12,128)	$ 3	(12,131)
Issuance of common stock under the employee stock purchase plan (in shares)		35
Issuance of common stock under the employee stock purchase plan	2,446		2,446
Stock-based compensation	28,227		28,227
Cash dividends declared	(2,455)			(2,455)
Other comprehensive (loss) income	(2,548)				(2,548)
Net (loss)	(379)			(379)
Balance, end of period (in shares) at Mar. 31, 2022		81,802
Balance, end of period at Mar. 31, 2022	406,668	$ 818	141,771	273,615	(9,536)
Balance, beginning of period (in shares) at Dec. 31, 2021		81,712
Balance, beginning of period at Dec. 31, 2021	416,088	$ 817	145,810	276,449	(6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive (loss) income	(21,936)
Net (loss)	(380,195)
Balance, end of period (in shares) at Sep. 30, 2022		82,164
Balance, end of period at Sep. 30, 2022	64,961	$ 822	204,189	(111,126)	(28,924)
Balance, beginning of period (in shares) at Mar. 31, 2022		81,802
Balance, beginning of period at Mar. 31, 2022	406,668	$ 818	141,771	273,615	(9,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(38)
Repurchase of common stock	(1,925)		(1,925)
Issuance of common stock for stock compensation plans (in shares)		117
Issuance of common stock for stock compensation plans	(3,251)	$ 1	(3,252)
Issuance of common stock under the employee stock purchase plan (in shares)		59
Issuance of common stock under the employee stock purchase plan	2,357		2,357
Stock-based compensation	31,300		31,300
Cash dividends declared	(2,459)			(2,459)
Other comprehensive (loss) income	(12,615)				(12,615)
Net (loss)	(286,296)			(286,296)
Balance, end of period (in shares) at Jun. 30, 2022		81,940
Balance, end of period at Jun. 30, 2022	133,779	$ 819	170,251	(15,140)	(22,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		138
Issuance of common stock for stock compensation plans	(2,196)	$ 2	(2,198)
Issuance of common stock under the employee stock purchase plan (in shares)		86
Issuance of common stock under the employee stock purchase plan	2,363	$ 1	2,362
Stock-based compensation	33,774		33,774
Cash dividends declared	(2,466)			(2,466)
Other comprehensive (loss) income	(6,773)				(6,773)
Net (loss)	(93,520)			(93,520)
Balance, end of period (in shares) at Sep. 30, 2022		82,164
Balance, end of period at Sep. 30, 2022	$ 64,961	$ 822	204,189	(111,126)	(28,924)
Balance, beginning of period (in shares) at Dec. 31, 2022	82,436	82,436
Balance, beginning of period at Dec. 31, 2022	$ 130,843	$ 824	229,602	(76,513)	(23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		452
Issuance of common stock for stock compensation plans	672	$ 4	668
Issuance of common stock under the employee stock purchase plan (in shares)		52
Issuance of common stock under the employee stock purchase plan	2,143	$ 1	2,142
Stock-based compensation	42,557		42,557
Cash dividends declared	(2,488)		(2,488)
Other comprehensive (loss) income	1,543				1,543
Net (loss)	(20,774)			(20,774)
Balance, end of period (in shares) at Mar. 31, 2023		82,940
Balance, end of period at Mar. 31, 2023	$ 154,496	$ 829	272,481	(97,287)	(21,527)
Balance, beginning of period (in shares) at Dec. 31, 2022	82,436	82,436
Balance, beginning of period at Dec. 31, 2022	$ 130,843	$ 824	229,602	(76,513)	(23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive (loss) income	(2,018)
Net (loss)	$ (74,857)
Balance, end of period (in shares) at Sep. 30, 2023	83,523	83,523
Balance, end of period at Sep. 30, 2023	$ 167,636	$ 835	343,259	(151,370)	(25,088)
Balance, beginning of period (in shares) at Mar. 31, 2023		82,940
Balance, beginning of period at Mar. 31, 2023	154,496	$ 829	272,481	(97,287)	(21,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		225
Issuance of common stock for stock compensation plans	1,826	$ 2	1,824
Issuance of common stock under the employee stock purchase plan (in shares)		47
Issuance of common stock under the employee stock purchase plan	1,981	$ 1	1,980
Stock-based compensation	36,227		36,227
Cash dividends declared	(2,496)		(2,496)
Other comprehensive (loss) income	166				166
Net (loss)	(46,804)			(46,804)
Balance, end of period (in shares) at Jun. 30, 2023		83,212
Balance, end of period at Jun. 30, 2023	145,396	$ 832	310,016	(144,091)	(21,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		257
Issuance of common stock for stock compensation plans	2,450	$ 3	2,447
Issuance of common stock under the employee stock purchase plan (in shares)		54
Issuance of common stock under the employee stock purchase plan	2,003		2,003
Stock-based compensation	31,299		31,299
Cash dividends declared	(2,506)		(2,506)
Other comprehensive (loss) income	(3,727)				(3,727)
Net (loss)	$ (7,279)			(7,279)
Balance, end of period (in shares) at Sep. 30, 2023	83,523	83,523
Balance, end of period at Sep. 30, 2023	$ 167,636	$ 835	$ 343,259	$ (151,370)	$ (25,088)